speb/financial-data huggingface dataset:
DuPont ROE decomposition for CAA.AX (annual period ending 2022-12-31)
ROE: 21.47992367941136%
Net margin: 6.3351490166085265%
Asset turnover: 1.4398742960489206
Equity multiplier (leverage): 2.3547853219906605
EBIT margin: -2.170270051796718%
Tax burden factor: 1.2582746696307276
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CAA.AX (annual period ending 2023-12-31)
ROE: 16.24877595528246%
Net margin: 5.178386712727131%
Asset turnover: 1.4200833314450265
Equity multiplier (leverage): 2.2095932830177594
EBIT margin: -1.2730058356265976%
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CAA.AX (annual period ending 2024-12-31)
ROE: 14.41000326200459%
Net margin: 5.375100513237966%
Asset turnover: 1.284175930926723
Equity multiplier (leverage): 2.087627280687915
EBIT margin: -2.690776607467265%
Tax burden factor: 1.125012986113516
ROE archetype: Standard Business
DuPont ROE decomposition for CAA.AX (annual period ending 2025-12-31)
ROE: 15.758306040880507%
Net margin: 5.192999231822097%
Asset turnover: 1.49121590696128
Equity multiplier (leverage): 2.034935951401395
EBIT margin: 4.358790097939039%
Interest burden factor: 1.1091194863391634
Tax burden factor: 1.0741723451727672
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CAF.MC (annual period ending 2022-12-31)
ROE: 6.95956616877557%
Net margin: 1.733202336461884%
Asset turnover: 0.6393483614106638
Equity multiplier (leverage): 6.280516284527322
EBIT margin: 4.3212224409013515%
Interest burden factor: 0.6661086214333233
Tax burden factor: 0.6021401525544642
ROE archetype: Standard Business
DuPont ROE decomposition for CAF.MC (annual period ending 2023-12-31)
ROE: 11.376358223666292%
Net margin: 2.4133365226381827%
Asset turnover: 0.7812477818224662
Equity multiplier (leverage): 6.033878712927683
EBIT margin: 4.735882424446806%
Interest burden factor: 0.7764253895706029
Tax burden factor: 0.6563224274481366
ROE archetype: Standard Business
DuPont ROE decomposition for CAF.MC (annual period ending 2024-12-31)
ROE: 11.814217192781348%
Net margin: 2.555975327807409%
Asset turnover: 0.7942535142695338
Equity multiplier (leverage): 5.8195465740185925
EBIT margin: 5.092147937228706%
Interest burden factor: 0.7490044670751383
Tax burden factor: 0.6701487891427503
ROE archetype: Standard Business
DuPont ROE decomposition for CAF.MC (annual period ending 2025-12-31)
ROE: 16.994133711953822%
Net margin: 3.373651018804271%
Asset turnover: 0.8839458071960462
Equity multiplier (leverage): 5.698666412485706
EBIT margin: 5.38072373908233%
Interest burden factor: 0.8932554016436903
Tax burden factor: 0.7019138467531384
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CAG (annual period ending 2022-05-31)
ROE: 10.02234208210151%
Net margin: 7.699442609592663%
Asset turnover: 0.5141898186324109
Equity multiplier (leverage): 2.5315497280584958
EBIT margin: 11.667923612375281%
Interest burden factor: 0.875705794947994
Tax burden factor: 0.7535420378382964
ROE archetype: Standard Business
DuPont ROE decomposition for CAG (annual period ending 2023-05-31)
ROE: 7.737626984351566%
Net margin: 5.5681355379978825%
Asset turnover: 0.5519278362333858
Equity multiplier (leverage): 2.517767905147288
EBIT margin: 14.92954304797589%
Interest burden factor: 0.492061760052376
Tax burden factor: 0.757955427430979
ROE archetype: Standard Business
DuPont ROE decomposition for CAG (annual period ending 2024-05-31)
ROE: 4.015336112618803%
Net margin: 2.885261681700122%
Asset turnover: 0.5616184588569472
Equity multiplier (leverage): 2.4779658863880454
EBIT margin: 15.317528151424376%
Interest burden factor: 0.33057045343734764
Tax burden factor: 0.5698131760078663
ROE archetype: Low Return
DuPont ROE decomposition for CAG (annual period ending 2025-05-31)
ROE: 13.213712451272643%
Net margin: 9.924393772389088%
Asset turnover: 0.5556868806255114
Equity multiplier (leverage): 2.3960215546892916
EBIT margin: 12.62572333976302%
Interest burden factor: 0.7885690901650525
Tax burden factor: 0.9967998616156374
ROE archetype: Standard Business
DuPont ROE decomposition for CAG (annual period ending 2026-05-31)
ROE: -25.064256424007375%
Net margin: -16.985179407176286%
Asset turnover: 0.590531376690405
Equity multiplier (leverage): 2.4988587535888764
EBIT margin: 11.159764572401079%
Interest burden factor: -1.4490865766481333
ROE archetype: Low Return
DuPont ROE decomposition for CAKE (quarterly period ending 2025-03-31)
ROE: 9.705514061372106%
Net margin: 3.5527509256393195%
Asset turnover: 0.2980512809303139
Equity multiplier (leverage): 9.165639869772102
EBIT margin: 6.624482175848283%
Interest burden factor: 0.5614112207352414
Tax burden factor: 0.9552823130238088
ROE archetype: Standard Business
DuPont ROE decomposition for CAKE (quarterly period ending 2025-06-30)
ROE: 14.806990719292013%
Net margin: 5.734522532890435%
Asset turnover: 0.30524043042948423
Equity multiplier (leverage): 8.459164749788277
EBIT margin: 7.857400674809719%
Interest burden factor: 0.8285820806092966
Tax burden factor: 0.8808111973517171
ROE archetype: Standard Business
DuPont ROE decomposition for CAKE (quarterly period ending 2025-09-30)
ROE: 7.720952635674581%
Net margin: 3.5161029335579004%
Asset turnover: 0.28380709803984133
Equity multiplier (leverage): 7.737239757617418
EBIT margin: 4.922588197428205%
Interest burden factor: 0.794487113459773
Tax burden factor: 0.8990445590597784
ROE archetype: Standard Business
DuPont ROE decomposition for CAKE (quarterly period ending 2025-12-31)
ROE: 6.678069475130428%
Net margin: 2.9925391916036266%
Asset turnover: 0.29572632802021703
Equity multiplier (leverage): 7.546074617998181
EBIT margin: 7.968318083776538%
Interest burden factor: 0.40070477682067346
Tax burden factor: 0.937235359259983
ROE archetype: Standard Business
DuPont ROE decomposition for CAKE (quarterly period ending 2026-03-31)
ROE: 11.064106300096132%
Net margin: 5.061946215544428%
Asset turnover: 0.29846960205750467
Equity multiplier (leverage): 7.323163099995199
EBIT margin: 6.389854040474728%
Interest burden factor: 0.8529882006842964
Tax burden factor: 0.9287173623737137
ROE archetype: Standard Business
DuPont ROE decomposition for CAM.V (annual period ending 2022-12-31)
ROE: -419.2760928690992%
Asset turnover: 0
Equity multiplier (leverage): 1.2277790645752096
ROE archetype: Low Return
DuPont ROE decomposition for CAM.V (annual period ending 2023-12-31)
ROE: -362.43372876443317%
Asset turnover: 0
Equity multiplier (leverage): 1.1351717245349626
ROE archetype: Low Return
DuPont ROE decomposition for CAM.V (annual period ending 2024-12-31)
ROE: -222.41937006536227%
Asset turnover: 0
Equity multiplier (leverage): 1.1152518428129437
ROE archetype: Low Return
DuPont ROE decomposition for CAM.V (annual period ending 2025-12-31)
ROE: -40.90043180255532%
Asset turnover: 0
Equity multiplier (leverage): 1.1303040081024522
ROE archetype: Low Return
DuPont ROE decomposition for CAN.AX (annual period ending 2021-06-30)
ROE: -27.32388540578196%
Net margin: -584.7426042394596%
Asset turnover: 0.04217423766111286
Equity multiplier (leverage): 1.1079763148728667
EBIT margin: -548.4509666899604%
ROE archetype: Low Return
DuPont ROE decomposition for CAN.AX (annual period ending 2022-06-30)
ROE: -28.604127183823508%
Net margin: -412.8529090625488%
Asset turnover: 0.051157192980750964
Equity multiplier (leverage): 1.3543366925008224
EBIT margin: -453.5017937919202%
ROE archetype: Low Return
DuPont ROE decomposition for CAN.AX (annual period ending 2023-06-30)
ROE: -45.76196418675996%
Net margin: -245.26384553966753%
Asset turnover: 0.10022983726000732
Equity multiplier (leverage): 1.8615473970772607
EBIT margin: -265.536764172171%
ROE archetype: Low Return
DuPont ROE decomposition for CAN.AX (annual period ending 2024-06-30)
ROE: -140.79494898701427%
Net margin: -333.32466011838943%
Asset turnover: 0.13888361308963137
Equity multiplier (leverage): 3.0413655589310777
EBIT margin: -178.8915631301633%
ROE archetype: Low Return
DuPont ROE decomposition for CANB.V (quarterly period ending 2024-10-31)
ROE: 3.8201237288191963%
Net margin: 3.3488238309280787%
Asset turnover: 0.36515477858243467
Equity multiplier (leverage): 3.123979241993479
EBIT margin: 4.360763913694489%
Interest burden factor: 0.7679443091178297
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CANB.V (quarterly period ending 2025-01-31)
ROE: 1.1206997116665027%
Net margin: 1.077206964405277%
Asset turnover: 0.3396132470062095
Equity multiplier (leverage): 3.0634125383974378
EBIT margin: 2.1096771124446816%
Interest burden factor: 0.6159718453814097
Tax burden factor: 0.8289384777235134
ROE archetype: Low Return
DuPont ROE decomposition for CANB.V (quarterly period ending 2025-04-30)
ROE: -0.26104399605206%
Net margin: -0.39868136695103434%
Asset turnover: 0.22388278283191163
Equity multiplier (leverage): 2.9246040283624857
EBIT margin: 2.4857559434347594%
Interest burden factor: -0.16038636777838527
ROE archetype: Low Return
DuPont ROE decomposition for CANB.V (quarterly period ending 2025-07-31)
ROE: -14.771568727744858%
Net margin: -19.206406704478955%
Asset turnover: 0.25899989735571727
Equity multiplier (leverage): 2.969483431817334
EBIT margin: -4.546035050874743%
ROE archetype: Low Return
DuPont ROE decomposition for CANB.V (quarterly period ending 2025-10-31)
ROE: -1.6235621896716905%
Net margin: -2.2434937477004624%
Asset turnover: 0.23229381075843525
Equity multiplier (leverage): 3.1153469954635202
EBIT margin: 2.0807370808732206%
Interest burden factor: -1.078220678779338
ROE archetype: Low Return
DuPont ROE decomposition for CANFINHOME.NS (annual period ending 2023-03-31)
ROE: 17.03220149210865%
Net margin: 61.37904684140312%
Asset turnover: 0.03060407595286219
Equity multiplier (leverage): 9.067161998171073
Tax burden factor: 0.7538694203147767
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CANFINHOME.NS (annual period ending 2024-03-31)
ROE: 18.65450914454013%
Net margin: 59.190595783118084%
Asset turnover: 0.03592649525040841
Equity multiplier (leverage): 8.772356287979866
Tax burden factor: 0.7839938199415706
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CANFINHOME.NS (annual period ending 2025-03-31)
ROE: 18.001359473941257%
Net margin: 62.75195683147552%
Asset turnover: 0.03480932607269822
Equity multiplier (leverage): 8.24104747663668
Tax burden factor: 0.7955349315331667
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CANFINHOME.NS (annual period ending 2026-03-31)
ROE: 18.76774808053976%
Net margin: 65.93914820951376%
Asset turnover: 0.03697195041089103
Equity multiplier (leverage): 7.698329058675348
Tax burden factor: 0.8329098536843421
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CANG (quarterly period ending 2024-12-31)
ROE: 1.1345959386076183%
Net margin: 6.925224343317766%
Asset turnover: 0.11096255870739095
Equity multiplier (leverage): 1.4764913771756043
EBIT margin: 6.689324097372143%
Interest burden factor: 1.038034181623321
Tax burden factor: 0.9973324601922249
ROE archetype: Low Return
DuPont ROE decomposition for CANG (quarterly period ending 2025-03-31)
ROE: -5.923894940102442%
Net margin: -22.319821671880096%
Asset turnover: 0.16115215010058398
Equity multiplier (leverage): 1.6469504114534075
EBIT margin: -0.11792939894312783%
ROE archetype: Low Return
DuPont ROE decomposition for CANG (quarterly period ending 2025-06-30)
ROE: -49.64409912727128%
Net margin: -211.22795313459036%
Asset turnover: 0.13346221583924164
Equity multiplier (leverage): 1.7609941468077537
EBIT margin: -1.9728735843506386%
ROE archetype: Low Return
DuPont ROE decomposition for CANG (quarterly period ending 2025-09-30)
ROE: 5.551457935728992%
Net margin: 16.613537021085367%
Asset turnover: 0.18270511794234595
Equity multiplier (leverage): 1.8289180112608152
EBIT margin: 9.010409025360342%
Interest burden factor: 1.922942296467723
Tax burden factor: 0.9588514852278825
ROE archetype: Standard Business
DuPont ROE decomposition for CANG (quarterly period ending 2025-12-31)
ROE: -53.74585539509752%
Net margin: -162.55233999805284%
Asset turnover: 0.14528420977968137
Equity multiplier (leverage): 2.275796043529424
EBIT margin: -13.261043374939078%
ROE archetype: Low Return
DuPont ROE decomposition for CANG (quarterly period ending 2026-03-31)
ROE: -85.89398617002223%
Net margin: -255.9316496397721%
Asset turnover: 0.13477183927435948
Equity multiplier (leverage): 2.490230836072792
EBIT margin: -32.51659415364072%
ROE archetype: Low Return
DuPont ROE decomposition for CANX.V (quarterly period ending 2024-12-31)
ROE: -2.996480448330913%
Asset turnover: 0
Equity multiplier (leverage): 1.026843637220262
ROE archetype: Low Return
DuPont ROE decomposition for CANX.V (quarterly period ending 2025-03-31)
ROE: -0.43856425253960307%
Asset turnover: 0
Equity multiplier (leverage): 1.0241474367321886
ROE archetype: Low Return
DuPont ROE decomposition for CANX.V (quarterly period ending 2025-06-30)
ROE: -0.8277667077369233%
Asset turnover: 0
Equity multiplier (leverage): 1.0293487038829439
ROE archetype: Low Return
DuPont ROE decomposition for CANX.V (quarterly period ending 2025-09-30)
ROE: -3.126985811276123%
Asset turnover: 0
Equity multiplier (leverage): 1.0397142999620437
ROE archetype: Low Return
DuPont ROE decomposition for CANX.V (quarterly period ending 2025-12-31)
ROE: -2.6809338405274863%
Asset turnover: 0
Equity multiplier (leverage): 1.0362114519481136
ROE archetype: Low Return
DuPont ROE decomposition for CANX.V (quarterly period ending 2026-03-31)
ROE: -2.83006157326979%
Asset turnover: 0
Equity multiplier (leverage): 1.0488685972602942
ROE archetype: Low Return
DuPont ROE decomposition for CAPILLARY.NS (quarterly period ending 2024-12-31)
Net margin: 6.452830188679245%
EBIT margin: 6.364779874213837%
Interest burden factor: 0.9826086956521739
Tax burden factor: 1.0317779565567176
ROE archetype: Standard Business
DuPont ROE decomposition for CAPILLARY.NS (quarterly period ending 2025-03-31)
ROE: 1.731993305727967%
Net margin: 6.471508791309952%
Asset turnover: 0.1813405766859754
Equity multiplier (leverage): 1.4758617291424327
EBIT margin: 7.2579266448363375%
Interest burden factor: 1.0826236637071933
Tax burden factor: 0.8235983263598327
ROE archetype: Low Return
DuPont ROE decomposition for CAPILLARY.NS (quarterly period ending 2025-09-30)
Equity multiplier (leverage): 1.4863457854149584
ROE archetype: Standard Business
DuPont ROE decomposition for CAPILLARY.NS (quarterly period ending 2025-12-31)
Net margin: 4.3421088379927735%
EBIT margin: 3.203195044420898%
Interest burden factor: 1.3772688719253605
Tax burden factor: 0.9842345116393645
ROE archetype: Standard Business
DuPont ROE decomposition for CAPILLARY.NS (quarterly period ending 2026-03-31)
ROE: 4.23686336887502%
Net margin: 22.662611186019042%
Asset turnover: 0.14716183602744723
Equity multiplier (leverage): 1.2703965733033837
EBIT margin: 6.207602980987321%
Interest burden factor: 3.575938710220576
Tax burden factor: 1.0209299587992935
ROE archetype: Low Return
DuPont ROE decomposition for CAPT.OL (annual period ending 2023-12-31)
Equity multiplier (leverage): 1.0017590149516271
ROE archetype: Standard Business
DuPont ROE decomposition for CAPT.OL (annual period ending 2024-12-31)
ROE: 0%
Asset turnover: 0
Equity multiplier (leverage): 1.006497616679369
ROE archetype: Low Return
DuPont ROE decomposition for CAPT.OL (annual period ending 2025-12-31)
ROE: 5.287986070630674%
Net margin: 37.00477934932918%
Asset turnover: 0.12367695063809982
Equity multiplier (leverage): 1.1554302000431949
EBIT margin: 36.696669011863456%
Interest burden factor: 1.0083961390982414
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CAR.L (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 116.22222222222223
ROE archetype: Standard Business
DuPont ROE decomposition for CARL (annual period ending 2023-12-31)
Net margin: -137.16069095659748%
Asset turnover: 0.9824586423274386
EBIT margin: -134.93250108869213%
ROE archetype: Standard Business
DuPont ROE decomposition for CARL (annual period ending 2024-12-31)
Net margin: -89.29504877599854%
Asset turnover: 0.8250820070465315
EBIT margin: -88.79808577213326%
ROE archetype: Standard Business
DuPont ROE decomposition for CARL (annual period ending 2025-12-31)
ROE: -209.87995325613517%
Net margin: -58.66840886143613%
Asset turnover: 0.5552367761509036
Equity multiplier (leverage): 6.443004355678317
EBIT margin: -60.52938963790066%
ROE archetype: Low Return
DuPont ROE decomposition for CASY (annual period ending 2022-04-30)
ROE: 15.163523646064553%
Net margin: 2.6233355264590243%
Asset turnover: 2.3525661447255857
Equity multiplier (leverage): 2.456995998818299
EBIT margin: 3.8424735616664893%
Interest burden factor: 0.8855294354028531
Tax burden factor: 0.7709743878310432
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CASY (annual period ending 2023-04-30)
ROE: 18.226691235996135%
Net margin: 2.959301333766163%
Asset turnover: 2.6368198095903574
Equity multiplier (leverage): 2.3358136604601363
EBIT margin: 4.235543137472487%
Interest burden factor: 0.918954597995098
Tax burden factor: 0.7603018120295889
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CASY (annual period ending 2024-04-30)
ROE: 17.6873799670792%
Net margin: 3.3773460155489037%
Asset turnover: 2.4185618999987226
Equity multiplier (leverage): 2.165363147979571
EBIT margin: 4.774306355692185%
Interest burden factor: 0.924688663065582
Tax burden factor: 0.7650146305779079
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CASY (annual period ending 2025-04-30)
ROE: 16.754007594361234%
Net margin: 3.4284139181861697%
Asset turnover: 2.1903532198815423
Equity multiplier (leverage): 2.231060272214304
EBIT margin: 4.995954117769644%
Interest burden factor: 0.8945868910095429
Tax burden factor: 0.7671005222829985
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CASY (annual period ending 2026-04-30)
ROE: 19.153103142476887%
Net margin: 4.068355395256824%
Asset turnover: 2.04863786663842
Equity multiplier (leverage): 2.2980266846675153
EBIT margin: 5.886060333005317%
Interest burden factor: 0.9065125085013694
Tax burden factor: 0.7624658092704235
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CAV.AX (annual period ending 2021-06-30)
ROE: -21.695668108957335%
Equity multiplier (leverage): 1.0425539458341455
ROE archetype: Low Return
DuPont ROE decomposition for CAV.AX (annual period ending 2022-06-30)
ROE: -17.187837375616468%
Equity multiplier (leverage): 1.0514070080810947
ROE archetype: Low Return
DuPont ROE decomposition for CAV.AX (annual period ending 2023-06-30)
ROE: -5.046678950739927%
Equity multiplier (leverage): 1.0517316569482065
ROE archetype: Low Return
DuPont ROE decomposition for CAV.AX (annual period ending 2024-06-30)
ROE: -8.033078174547557%
Equity multiplier (leverage): 1.0362874944535494
ROE archetype: Low Return
DuPont ROE decomposition for CAV.L (annual period ending 2022-03-31)
ROE: 19.69270786075069%
Net margin: 12.39128366162337%
Asset turnover: 0.788750788075295
Equity multiplier (leverage): 2.0148806823337266
EBIT margin: 16.484917689599392%
Interest burden factor: 0.9356961440775803
Tax burden factor: 0.8033312769895127
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CAV.L (annual period ending 2023-03-31)
ROE: -18.02997012617858%
Net margin: -16.790408958130477%
Asset turnover: 0.5345271142075148
Equity multiplier (leverage): 2.0089262471089766
EBIT margin: -5.093719571567673%
ROE archetype: Low Return
DuPont ROE decomposition for CAV.L (annual period ending 2024-03-31)
ROE: -10.919212177164908%
Net margin: -7.37398103476959%
Asset turnover: 0.7379028637267966
Equity multiplier (leverage): 2.0067353123374216
EBIT margin: -7.355265346864083%
ROE archetype: Low Return
DuPont ROE decomposition for CAV.L (annual period ending 2025-03-31)
ROE: 1.9500143262407688%
Net margin: 1.3747618876469108%
Asset turnover: 0.7185210023159703
Equity multiplier (leverage): 1.9741077397838414
EBIT margin: 1.8473924450993784%
Interest burden factor: 0.7276264591439688
Tax burden factor: 1.0227272727272727
ROE archetype: Low Return
DuPont ROE decomposition for CAVEN.OL (annual period ending 2022-12-31)
ROE: -1310.4768534632776%
Net margin: -367.2454155286773%
Asset turnover: 0.24923723971945008
Equity multiplier (leverage): 14.317264183780008
EBIT margin: -204.48692937963324%
ROE archetype: Low Return
DuPont ROE decomposition for CAVEN.OL (annual period ending 2023-12-31)
ROE: -211.76922216263554%
Net margin: -100.00692352961539%
Asset turnover: 0.37355492883284924
Equity multiplier (leverage): 5.668632506991374
EBIT margin: -83.28659950842939%
ROE archetype: Low Return
DuPont ROE decomposition for CAVEN.OL (annual period ending 2024-12-31)
ROE: -47.0080103171194%
Net margin: -73.39955493920728%
Asset turnover: 0.3584835625494279
Equity multiplier (leverage): 1.78652540332671
EBIT margin: -75.9505918018512%
ROE archetype: Low Return
DuPont ROE decomposition for CAVEN.OL (annual period ending 2025-12-31)
ROE: -46.956908964082054%
Net margin: -174.0414135475864%
Asset turnover: 0.21341798164588552
Equity multiplier (leverage): 1.2642003044176775
EBIT margin: -156.6137566137566%
ROE archetype: Low Return
DuPont ROE decomposition for CBAV.MC (quarterly period ending 2025-03-31)
ROE: 11.55406739797842%
Net margin: 16.045427346165354%
Asset turnover: 0.3482519243376067
Equity multiplier (leverage): 2.06771216718433
EBIT margin: 22.933080682158174%
Interest burden factor: 0.98162644053055
Tax burden factor: 0.7127588880274671
ROE archetype: Standard Business
DuPont ROE decomposition for CBAV.MC (quarterly period ending 2025-06-30)
ROE: 10.222705589589134%
Net margin: 13.33870101986044%
Asset turnover: 0.3425669763174315
Equity multiplier (leverage): 2.237210355463935
EBIT margin: 19.857756307031668%
Interest burden factor: 0.9701310987971348
Tax burden factor: 0.6923934243521873
ROE archetype: Standard Business
DuPont ROE decomposition for CBAV.MC (quarterly period ending 2025-09-30)
ROE: 6.326855787707308%
Net margin: 9.151327677559646%
Asset turnover: 0.2900596536269672
Equity multiplier (leverage): 2.3835074030353236
EBIT margin: 13.152736516492602%
Interest burden factor: 0.952497380370241
Tax burden factor: 0.7304730473047305
ROE archetype: Standard Business
DuPont ROE decomposition for CBAV.MC (quarterly period ending 2025-12-31)
ROE: 14.05361496786513%
Net margin: 17.907129256183886%
Asset turnover: 0.3438108747195257
Equity multiplier (leverage): 2.282666541498551
EBIT margin: 23.066427582735006%
Interest burden factor: 1.0350021412878754
Tax burden factor: 0.7500744666138232
ROE archetype: Standard Business
DuPont ROE decomposition for CBAV.MC (quarterly period ending 2026-03-31)
ROE: 12.296888408628272%
Net margin: 16.901602777841653%
Asset turnover: 0.33632681063938585
Equity multiplier (leverage): 2.163245715966406
EBIT margin: 22.686090095890723%
Interest burden factor: 1.019005625665197
Tax burden factor: 0.7311250373022978
ROE archetype: Standard Business
DuPont ROE decomposition for CBKD.L (quarterly period ending 2024-12-31)
ROE: 8.447121682997142%
Net margin: 88.96273179262519%
Asset turnover: 0.011942965714370566
Equity multiplier (leverage): 7.950390389445589
Tax burden factor: 0.6972406867560699
ROE archetype: Standard Business
DuPont ROE decomposition for CBKD.L (quarterly period ending 2025-03-31)
ROE: 10.72018285347985%
Net margin: 60.927816490929686%
Asset turnover: 0.022086142324045165
Equity multiplier (leverage): 7.966484443082802
Tax burden factor: 0.7326885639635067
ROE archetype: Standard Business
DuPont ROE decomposition for CBKD.L (quarterly period ending 2025-06-30)
ROE: 10.050053748577703%
Net margin: 55.86737617770743%
Asset turnover: 0.023365853493858856
Equity multiplier (leverage): 7.698896123466986
Tax burden factor: 0.7094752140428077
ROE archetype: Standard Business
DuPont ROE decomposition for CBKD.L (quarterly period ending 2025-12-31)
ROE: 8.707262635593295%
Net margin: 62.121251155227085%
Asset turnover: 0.02249598771328094
Equity multiplier (leverage): 6.230693442767305
Tax burden factor: 0.7125328947170759
ROE archetype: Standard Business
DuPont ROE decomposition for CBKD.L (quarterly period ending 2026-03-31)
ROE: 7.42107705867201%
Net margin: 53.57288593643903%
Asset turnover: 0.02070114514167733
Equity multiplier (leverage): 6.691562346609697
Tax burden factor: 0.6971787241721493
ROE archetype: Standard Business
DuPont ROE decomposition for CBKD.L (quarterly period ending 2026-06-30)
ROE: 9.909240738596283%
Net margin: 59.414866646468845%
Asset turnover: 0.02328229066119549
Equity multiplier (leverage): 7.163405664036059
Tax burden factor: 0.7515654083612636
ROE archetype: Standard Business
DuPont ROE decomposition for CBLL (annual period ending 2022-12-31)
Net margin: -143.36856724018207%
Asset turnover: 0.2998218788313401
EBIT margin: -138.95918524805185%
ROE archetype: Standard Business
DuPont ROE decomposition for CBLL (annual period ending 2023-12-31)
Net margin: -65.14980652294085%
Asset turnover: 0.6221626083367726
EBIT margin: -66.42564953012715%
ROE archetype: Standard Business
DuPont ROE decomposition for CBLL (annual period ending 2024-12-31)
ROE: -102.53063500310469%
Net margin: -61.81620927816148%
Asset turnover: 0.4603318632312703
Equity multiplier (leverage): 3.6031325637094014
EBIT margin: -60.676303404437384%
ROE archetype: Low Return
DuPont ROE decomposition for CBLL (annual period ending 2025-12-31)
ROE: -30.829348255849187%
Net margin: -59.97103174157618%
Asset turnover: 0.4228861745189511
Equity multiplier (leverage): 1.2156241973327637
EBIT margin: -65.57380730494144%
ROE archetype: Low Return
DuPont ROE decomposition for CBNA (quarterly period ending 2025-03-31)
ROE: 3.7008679581531965%
Net margin: 38.48318462594372%
Asset turnover: 0.00843727922356184
Equity multiplier (leverage): 11.3980396686578
Tax burden factor: 0.7967884041494955
ROE archetype: Low Return
DuPont ROE decomposition for CBNA (quarterly period ending 2025-06-30)
ROE: 2.97225185036294%
Net margin: 36.22856239626966%
Asset turnover: 0.007977964600737644
Equity multiplier (leverage): 10.28353428237041
Tax burden factor: 0.793491431538861
ROE archetype: Low Return
DuPont ROE decomposition for CBNA (quarterly period ending 2025-09-30)
ROE: 2.9383459774281038%
Net margin: 35.80021318714786%
Asset turnover: 0.008816297598038854
Equity multiplier (leverage): 9.309601179837772
Tax burden factor: 0.7976251060220526
ROE archetype: Low Return
DuPont ROE decomposition for CBNA (quarterly period ending 2025-12-31)
ROE: 3.216225569113642%
Net margin: 36.35621470848357%
Asset turnover: 0.008949833077301983
Equity multiplier (leverage): 9.884459022313166
Tax burden factor: 0.7968983000298241
ROE archetype: Low Return
DuPont ROE decomposition for CBNA (quarterly period ending 2026-03-31)
ROE: 4.110504687672554%
Net margin: 40.68576688528363%
Asset turnover: 0.009474872808472331
Equity multiplier (leverage): 10.662996158026585
Tax burden factor: 0.7947853450213531
ROE archetype: Low Return
DuPont ROE decomposition for CBRL (quarterly period ending 2025-01-31)
ROE: 4.818025015458382%
Net margin: 2.3389601648973763%
Asset turnover: 0.44169054367946514
Equity multiplier (leverage): 4.663673345410759
EBIT margin: 3.3255427678871414%
Interest burden factor: 0.7647114714638626
Tax burden factor: 0.9197349347691033
ROE archetype: Low Return
DuPont ROE decomposition for CBRL (quarterly period ending 2025-04-30)
ROE: 2.7034290591748675%
Net margin: 1.5312727197444551%
Asset turnover: 0.38294354855633744
Equity multiplier (leverage): 4.610283952501865
EBIT margin: 1.8967371250214637%
Interest burden factor: 0.6339004815409309
Tax burden factor: 1.2735743948141396
ROE archetype: Low Return
DuPont ROE decomposition for CBRL (quarterly period ending 2025-07-31)
ROE: 1.4509129967776584%
Net margin: 0.7781025311949531%
Asset turnover: 0.40363753632060767
Equity multiplier (leverage): 4.619691729323308
EBIT margin: 2.3234782127835083%
Interest burden factor: 0.12192582308607695
Tax burden factor: 2.746644977633184
ROE archetype: Low Return
DuPont ROE decomposition for CBRL (quarterly period ending 2025-10-31)
ROE: -5.530194046427845%
Net margin: -3.088606451677647%
Asset turnover: 0.3696454049352021
Equity multiplier (leverage): 4.843870057734399
EBIT margin: -3.678429680326347%
ROE archetype: Low Return
DuPont ROE decomposition for CBRL (quarterly period ending 2026-01-31)
ROE: 0.30002515811583264%
Net margin: 0.14654493454059533%
Asset turnover: 0.41117685572381557
Equity multiplier (leverage): 4.979184291974561
EBIT margin: 0.10070677638866186%
Interest burden factor: -4.052213393870602
ROE archetype: Low Return
DuPont ROE decomposition for CBRL (quarterly period ending 2026-04-30)
ROE: 9.606449926343295%
Net margin: 5.369045872226967%
Asset turnover: 0.3804514123065905
Equity multiplier (leverage): 4.702909355691761
EBIT margin: 0.8427737792007947%
Interest burden factor: 7.511011904761904
Tax burden factor: 0.8481792606094227
ROE archetype: Standard Business
DuPont ROE decomposition for CBU (annual period ending 2022-12-31)
ROE: 12.120925046964468%
Net margin: 27.685230843962287%
Asset turnover: 0.04290035187059882
Equity multiplier (leverage): 10.205323176763624
Tax burden factor: 0.7826468703446324
ROE archetype: Standard Business
DuPont ROE decomposition for CBU (annual period ending 2023-12-31)
ROE: 8.119294371503075%
Net margin: 20.23756015321909%
Asset turnover: 0.04153219779529453
Equity multiplier (leverage): 9.65995761994706
Tax burden factor: 0.7841836522400747
ROE archetype: Standard Business
DuPont ROE decomposition for CBU (annual period ending 2024-12-31)
ROE: 10.54568171494684%
Net margin: 24.45132874985093%
Asset turnover: 0.04672893012249749
Equity multiplier (leverage): 9.229673899349624
Tax burden factor: 0.7709216112883125
ROE archetype: Standard Business
DuPont ROE decomposition for CBU (annual period ending 2025-12-31)
ROE: 11.168071906983236%
Net margin: 25.718814310783927%
Asset turnover: 0.04857868987638226
Equity multiplier (leverage): 8.938846110066441
Tax burden factor: 0.7641960246047481
ROE archetype: Standard Business
DuPont ROE decomposition for CBZ (quarterly period ending 2025-03-31)
ROE: 6.412123877305125%
Net margin: 14.65047123317749%
Asset turnover: 0.1827531055514581
Equity multiplier (leverage): 2.3948898548650677
EBIT margin: 23.869768285494036%
Interest burden factor: 0.8644116941289394
Tax burden factor: 0.7100399051529698
ROE archetype: Standard Business
DuPont ROE decomposition for CBZ (quarterly period ending 2025-06-30)
ROE: 2.203678717492823%
Net margin: 6.136392897690697%
Asset turnover: 0.14983244863714698
Equity multiplier (leverage): 2.3967859034336656
EBIT margin: 8.818193522712642%
Interest burden factor: 0.9586375099548713
Tax burden factor: 0.7259038751103342
ROE archetype: Low Return
DuPont ROE decomposition for CBZ (quarterly period ending 2025-09-30)
ROE: 1.6019589535880407%
Net margin: 4.34494348662041%
Asset turnover: 0.15277090452539585
Equity multiplier (leverage): 2.4133849606312183
EBIT margin: 8.484069309242482%
Interest burden factor: 0.6864297363413971
Tax burden factor: 0.7460773152502104
ROE archetype: Low Return
DuPont ROE decomposition for CBZ (quarterly period ending 2025-12-31)
ROE: -4.3709371782008475%
Net margin: -14.63468119256334%
Asset turnover: 0.1212022059546123
Equity multiplier (leverage): 2.4642273545584783
EBIT margin: -15.69261217366948%
ROE archetype: Low Return
DuPont ROE decomposition for CBZ (quarterly period ending 2026-03-31)
ROE: 8.840331454993555%
Net margin: 19.04501525491439%
Asset turnover: 0.1877493504056867
Equity multiplier (leverage): 2.472343331665866
EBIT margin: 23.15034899520257%
Interest burden factor: 1.1528284694755382
Tax burden factor: 0.7136069801123318
ROE archetype: Standard Business
DuPont ROE decomposition for CCCC (quarterly period ending 2025-03-31)
ROE: -13.48877728810085%
Net margin: -363.66399557888917%
Asset turnover: 0.022652445512700143
Equity multiplier (leverage): 1.637409039663831
EBIT margin: -402.9289859077093%
ROE archetype: Low Return
DuPont ROE decomposition for CCCC (quarterly period ending 2025-06-30)
ROE: -14.095188567837836%
Net margin: -402.5994120377534%
Asset turnover: 0.020982029085254306
Equity multiplier (leverage): 1.6685924312846014
EBIT margin: -440.98715766671825%
ROE archetype: Low Return
DuPont ROE decomposition for CCCC (quarterly period ending 2025-09-30)
ROE: -19.585231009035777%
Net margin: -286.42920747996436%
Asset turnover: 0.0399633461740345
Equity multiplier (leverage): 1.7109981977154827
EBIT margin: -210.85485307212824%
ROE archetype: Low Return
DuPont ROE decomposition for CCCC (quarterly period ending 2025-12-31)
ROE: -9.96897772478984%
Net margin: -185.96586782861294%
Asset turnover: 0.0352758648847274
Equity multiplier (leverage): 1.5196364919281256
EBIT margin: -210.10348583877993%
ROE archetype: Low Return
DuPont ROE decomposition for CCCC (quarterly period ending 2026-03-31)
ROE: -10.239306975474397%
Net margin: -408.46879063719115%
Asset turnover: 0.017885384686947624
Equity multiplier (leverage): 1.4015654987225823
EBIT margin: -451.64174252275683%
ROE archetype: Low Return
DuPont ROE decomposition for CCCM.V (quarterly period ending 2024-11-30)
ROE: -0.7328198565203035%
Asset turnover: 0
Equity multiplier (leverage): 1.0058677755872507
ROE archetype: Low Return
DuPont ROE decomposition for CCCM.V (quarterly period ending 2025-02-28)
ROE: -1.31142986072989%
Asset turnover: 0
Equity multiplier (leverage): 1.0112924838375883
ROE archetype: Low Return
DuPont ROE decomposition for CCCM.V (quarterly period ending 2025-05-31)
ROE: -1.591061928000281%
Asset turnover: 0
Equity multiplier (leverage): 1.016836094589006
ROE archetype: Low Return
DuPont ROE decomposition for CCCM.V (quarterly period ending 2025-08-31)
ROE: -0.6437905899189104%
Asset turnover: 0
Equity multiplier (leverage): 1.0166647038787302
ROE archetype: Low Return
DuPont ROE decomposition for CCCM.V (quarterly period ending 2025-11-30)
ROE: -0.8755860787965135%
Asset turnover: 0
Equity multiplier (leverage): 1.0155201583945106
ROE archetype: Low Return
DuPont ROE decomposition for CCCM.V (quarterly period ending 2026-02-28)
ROE: -1.066342896997241%
Asset turnover: 0
Equity multiplier (leverage): 1.0144518161278666
ROE archetype: Low Return
DuPont ROE decomposition for CCCM.V (quarterly period ending 2026-05-31)
ROE: -0.9084501427901558%
Asset turnover: 0
Equity multiplier (leverage): 1.012704563944447
ROE archetype: Low Return
DuPont ROE decomposition for CCEC (annual period ending 2022-12-31)
ROE: 19.645346524107726%
Net margin: 66.97979193813683%
Asset turnover: 0.09377773237097625
Equity multiplier (leverage): 3.1276357792445797
EBIT margin: 46.21526071817657%
Interest burden factor: 0.9975617929488438
Tax burden factor: 1.4528426466499862
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CCEC (annual period ending 2023-12-31)
ROE: 5.2858821097601645%
Net margin: 21.536889359294875%
Asset turnover: 0.08677431027729714
Equity multiplier (leverage): 2.8284162619058555
EBIT margin: 46.752677968576066%
Interest burden factor: 0.08047423887587823
Tax burden factor: 5.724263368497635
ROE archetype: Standard Business
DuPont ROE decomposition for CCEC (annual period ending 2024-12-31)
ROE: 14.91654709803286%
Net margin: 57.02682087121447%
Asset turnover: 0.09100098917245396
Equity multiplier (leverage): 2.8743723689904006
EBIT margin: 52.33059146102625%
Interest burden factor: 0.3106006033046688
Tax burden factor: 3.508497916289183
ROE archetype: Standard Business
DuPont ROE decomposition for CCEC (annual period ending 2025-12-31)
ROE: 12.703136553492673%
Net margin: 43.482656236472074%
Asset turnover: 0.10151733038898653
Equity multiplier (leverage): 2.877760929194452
EBIT margin: 54.477140659933895%
Interest burden factor: 0.5300394979783579
Tax burden factor: 1.5058909642485494
ROE archetype: Standard Business
DuPont ROE decomposition for CCH.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 3.2254617014835
ROE archetype: Standard Business
DuPont ROE decomposition for CCH.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 2.942789730058859
ROE archetype: Standard Business
DuPont ROE decomposition for CCI (annual period ending 2022-12-31)
ROE: 22.486239763726676%
Net margin: 23.976524477526482%
Asset turnover: 0.17949179106395005
Equity multiplier (leverage): 5.224996643844811
EBIT margin: 34.82679645004294%
Interest burden factor: 0.6950267159884915
Tax burden factor: 0.9905381431105854
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CCI (annual period ending 2023-12-31)
ROE: 21.720896601590745%
Net margin: 31.727925644275455%
Asset turnover: 0.12224976758599318
Equity multiplier (leverage): 5.6
EBIT margin: 46.04985213350232%
Interest burden factor: 0.5770642201834862
Tax burden factor: 1.1939586645468998
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CCI (annual period ending 2024-12-31)
ROE: -124.93597951344431%
Net margin: -87.51121076233184%
Asset turnover: 0.12517014439470692
Equity multiplier (leverage): 11.405729833546735
EBIT margin: 49.30493273542601%
Interest burden factor: 0.5366075488858572
Tax burden factor: -3.307627118644068
ROE archetype: Low Return
DuPont ROE decomposition for CCI (annual period ending 2025-12-31)
Net margin: 10.412757973733584%
Asset turnover: 0.13272325458337225
EBIT margin: 48.92120075046904%
Interest burden factor: 0.5364333652924257
Tax burden factor: 0.3967828418230563
ROE archetype: Standard Business
DuPont ROE decomposition for CCMC.V (quarterly period ending 2024-12-31)
ROE: -548.0625645211629%
Asset turnover: 0
Equity multiplier (leverage): 1.7382121335798142
ROE archetype: Low Return
DuPont ROE decomposition for CCMC.V (quarterly period ending 2025-03-31)
ROE: -25.37659520986105%
Asset turnover: 0
Equity multiplier (leverage): 1.1373512181800138
ROE archetype: Low Return
DuPont ROE decomposition for CCMC.V (quarterly period ending 2025-06-30)
ROE: -12.860181165032458%
Asset turnover: 0
Equity multiplier (leverage): 1.0350958364960055
ROE archetype: Low Return
DuPont ROE decomposition for CCMC.V (quarterly period ending 2025-09-30)
ROE: -43.03545436317245%
Asset turnover: 0
Equity multiplier (leverage): 1.0209458857442957
ROE archetype: Low Return
DuPont ROE decomposition for CCMC.V (quarterly period ending 2025-12-31)
ROE: -157.00712383883697%
Asset turnover: 0
Equity multiplier (leverage): 1.0256422203733568
ROE archetype: Low Return
DuPont ROE decomposition for CCX.AX (annual period ending 2021-06-30)
ROE: 11.830890060976614%
Net margin: 8.339620159627355%
Asset turnover: 0.9681801836896754
Equity multiplier (leverage): 1.4652608931893898
EBIT margin: 12.160849901538628%
Interest burden factor: 1.0012407342601726
Tax burden factor: 0.684926283680732
ROE archetype: Standard Business
DuPont ROE decomposition for CCX.AX (annual period ending 2022-06-30)
ROE: 10.897869911181642%
Net margin: 6.02377385632933%
Asset turnover: 1.1442199221954645
Equity multiplier (leverage): 1.5811149862194136
EBIT margin: 9.264827563828694%
Interest burden factor: 0.9554037883431107
Tax burden factor: 0.6805254314953414
ROE archetype: Standard Business
DuPont ROE decomposition for CCX.AX (annual period ending 2023-06-30)
ROE: -60.177448022180094%
Net margin: -37.07606728671916%
Asset turnover: 0.8856463251681701
Equity multiplier (leverage): 1.8326510491770962
EBIT margin: -18.269377259704886%
ROE archetype: Low Return
DuPont ROE decomposition for CCX.AX (annual period ending 2024-06-30)
ROE: -126.39322659316741%
Net margin: -70.63454071591937%
Asset turnover: 0.698113720236979
Equity multiplier (leverage): 2.5631882392825
EBIT margin: -27.621631068256246%
ROE archetype: Low Return
DuPont ROE decomposition for CD1.AX (annual period ending 2022-03-31)
ROE: 22.68921029783726%
Asset turnover: -0.003829414843660181
Equity multiplier (leverage): 1.0354938514583294
Tax burden factor: 0.9073367458278998
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CD1.AX (annual period ending 2023-03-31)
ROE: 2.4154414548030125%
Asset turnover: -0.0030160150730000022
Equity multiplier (leverage): 1.0330616906897274
ROE archetype: Low Return
DuPont ROE decomposition for CD1.AX (annual period ending 2024-03-31)
ROE: 3.2103477400366836%
Net margin: 1161.7465629522433%
Asset turnover: 0.0026888677579401765
Equity multiplier (leverage): 1.0277115495705862
Tax burden factor: 1.589708204821007
ROE archetype: Low Return
DuPont ROE decomposition for CD1.AX (annual period ending 2025-03-31)
ROE: 2.051152123256186%
Net margin: 1214.8630899931836%
Asset turnover: 0.0016518973874266082
Equity multiplier (leverage): 1.0220860647237908
Tax burden factor: 1.4774688069295019
ROE archetype: Low Return
DuPont ROE decomposition for CD1.AX (annual period ending 2026-03-31)
ROE: -25.170746818018706%
Asset turnover: -0.01128786872114334
Equity multiplier (leverage): 1.0340703308432804
ROE archetype: Low Return
DuPont ROE decomposition for CDA.PA (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 2.8439513360915427
ROE archetype: Standard Business
DuPont ROE decomposition for CDA.PA (quarterly period ending 2025-03-31)
Equity multiplier (leverage): 2.77129356136567
ROE archetype: Standard Business
DuPont ROE decomposition for CDA.PA (quarterly period ending 2025-09-30)
Equity multiplier (leverage): 2.7560647082462486
ROE archetype: Standard Business
DuPont ROE decomposition for CDA.PA (quarterly period ending 2026-03-31)
Equity multiplier (leverage): 2.7649828986856613
ROE archetype: Standard Business
DuPont ROE decomposition for CDL.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.262428908029512
ROE archetype: Standard Business
DuPont ROE decomposition for CDL.L (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.7970294397065911
ROE archetype: Standard Business
DuPont ROE decomposition for CDNS (quarterly period ending 2025-03-31)
ROE: 5.727895295416474%
Net margin: 22.020805463124393%
Asset turnover: 0.1378341298804924
Equity multiplier (leverage): 1.887144263803225
EBIT margin: 29.088287992427354%
Interest burden factor: 0.9842521646009912
Tax burden factor: 0.7691457778077663
ROE archetype: Standard Business
DuPont ROE decomposition for CDNS (quarterly period ending 2025-06-30)
ROE: 3.2720914626137008%
Net margin: 12.548679241140908%
Asset turnover: 0.13772036818120367
Equity multiplier (leverage): 1.8933427512280487
EBIT margin: 29.04007319821144%
Interest burden factor: 0.7576007926801281
Tax burden factor: 0.5703742244491407
ROE archetype: Low Return
DuPont ROE decomposition for CDNS (quarterly period ending 2025-09-30)
ROE: 5.626787019599159%
Net margin: 21.44561179171789%
Asset turnover: 0.1401339933092837
Equity multiplier (leverage): 1.8723133709730206
EBIT margin: 33.81932690885678%
Interest burden factor: 0.8674804432999254
Tax burden factor: 0.7309939584961671
ROE archetype: Standard Business
DuPont ROE decomposition for CDNS (quarterly period ending 2025-12-31)
ROE: 7.27310681359066%
Net margin: 26.951755208268235%
Asset turnover: 0.14581646936509396
Equity multiplier (leverage): 1.850658702282159
EBIT margin: 32.304734208541824%
Interest burden factor: 1.059618464183997
Tax burden factor: 0.7873564034477373
ROE archetype: Standard Business
DuPont ROE decomposition for CDNS (quarterly period ending 2026-03-31)
ROE: 5.577765510511943%
Net margin: 22.768650540624876%
Asset turnover: 0.13250521245711863
Equity multiplier (leverage): 1.8488002802342776
EBIT margin: 29.25859098370664%
Interest burden factor: 0.992504683124061
Tax burden factor: 0.7840636482341866
ROE archetype: Standard Business
DuPont ROE decomposition for CDSL.NS (annual period ending 2023-03-31)
ROE: 21.951465134084376%
Net margin: 49.71476533039517%
Asset turnover: 0.3809348257238346
Equity multiplier (leverage): 1.1591174394209065
EBIT margin: 55.659349132423976%
Interest burden factor: 1.1818909190481415
Tax burden factor: 0.7557355890372919
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CDSL.NS (annual period ending 2024-03-31)
ROE: 30.13953815660841%
Net margin: 51.6529013122208%
Asset turnover: 0.49805489602885866
Equity multiplier (leverage): 1.1715603330407134
EBIT margin: 56.89985159862043%
Interest burden factor: 1.203038344099869
Tax burden factor: 0.7545779620425186
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CDSL.NS (annual period ending 2025-03-31)
ROE: 31.44207177718108%
Net margin: 48.66022977732433%
Asset turnover: 0.5425353288039867
Equity multiplier (leverage): 1.190992360072911
EBIT margin: 53.16394257839865%
Interest burden factor: 1.2077200256315737
Tax burden factor: 0.7578630050327895
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CDSL.NS (annual period ending 2026-03-31)
ROE: 22.85168226341853%
Net margin: 39.83966721829245%
Asset turnover: 0.4766417058021401
Equity multiplier (leverage): 1.2034011845650137
EBIT margin: 45.390637780656384%
Interest burden factor: 1.1718337942207016
Tax burden factor: 0.7490027266659058
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CEA.DE (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 19.03586371787206
ROE archetype: Standard Business
DuPont ROE decomposition for CEA.DE (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 2.8122224431629883
ROE archetype: Standard Business
DuPont ROE decomposition for CEC.V (annual period ending 2022-12-31)
ROE: -14.138065522620904%
Asset turnover: 0
Equity multiplier (leverage): 2.067082683307332
ROE archetype: Low Return
DuPont ROE decomposition for CEC.V (annual period ending 2023-12-31)
ROE: -64.33564776416503%
Asset turnover: 0
Equity multiplier (leverage): 2.1804663617621265
ROE archetype: Low Return
DuPont ROE decomposition for CEC.V (annual period ending 2024-12-31)
ROE: 17.58735608967885%
Asset turnover: 0
Equity multiplier (leverage): 2.0584351646132086
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CEC.V (annual period ending 2025-12-31)
ROE: -46.95506572948307%
Asset turnover: 0
Equity multiplier (leverage): 2.0557405260017574
ROE archetype: Low Return
DuPont ROE decomposition for CECO (annual period ending 2022-12-31)
ROE: 8.37183930175844%
Net margin: 4.321304601930307%
Asset turnover: 0.8373477624271627
Equity multiplier (leverage): 2.3136632011295086
EBIT margin: 6.611740376265596%
Interest burden factor: 0.8477615145116845
Tax burden factor: 0.7709485415171599
ROE archetype: Standard Business
DuPont ROE decomposition for CECO (annual period ending 2023-12-31)
ROE: 6.365126777997494%
Net margin: 2.661490882728115%
Asset turnover: 0.9861340872316319
Equity multiplier (leverage): 2.425191873390996
EBIT margin: 6.805054648569777%
Interest burden factor: 0.5805485880734688
Tax burden factor: 0.6736817653890824
ROE archetype: Standard Business
DuPont ROE decomposition for CECO (annual period ending 2024-12-31)
ROE: 5.893531459957824%
Net margin: 2.5847189537094954%
Asset turnover: 0.8204957389392569
Equity multiplier (leverage): 2.7789833750183903
EBIT margin: 7.100494145354371%
Interest burden factor: 0.44656199515347333
Tax burden factor: 0.815160250975072
ROE archetype: Standard Business
DuPont ROE decomposition for CECO (annual period ending 2025-12-31)
ROE: 18.469590922923096%
Net margin: 6.857993674948119%
Asset turnover: 0.9366749159947456
Equity multiplier (leverage): 2.875221492848759
EBIT margin: 6.677978927685467%
Interest burden factor: 1.602014967222942
Tax burden factor: 0.6410404973142616
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CEH.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.1276696811085425
ROE archetype: Standard Business
DuPont ROE decomposition for CENTA (annual period ending 2022-09-30)
ROE: 11.438572516018437%
Net margin: 4.572951199728747%
Asset turnover: 1.0172413057639818
Equity multiplier (leverage): 2.458958936459701
EBIT margin: 7.788801732948181%
Interest burden factor: 0.7649171653155717
Tax burden factor: 0.7675585452424764
ROE archetype: Standard Business
DuPont ROE decomposition for CENTA (annual period ending 2023-09-30)
ROE: 9.047237244509018%
Net margin: 3.809481514511872%
Asset turnover: 0.9939219145278614
Equity multiplier (leverage): 2.389449421978278
EBIT margin: 6.363767917602066%
Interest burden factor: 0.7711753368210172
Tax burden factor: 0.7762442672904676
ROE archetype: Standard Business